RJH Biosciences is a biotechnology company based out of Edmonton, Alberta, Canada. We develop novel transfection reagents and delivery systems that transport different types of nucleic acids to a range of human cells and cell lines. We develop value-added products in two commercial segments, as transfection reagents for biomedical R&D enterprise and as nucleic acid delivery vehicles for preclinical and clinical applications. The same transfection reagents are used in our own R&D projects that focus on blood cancers and modification of immune cells.
The company was founded by Dr. Hasan Uludag, Dr. Remant K.C, and Dr. Juliana Valencia-Serna in December 2016 based on a long history of technical expertise in transfection reagent and delivery vehicle development at the University of Alberta.